Navigation Links
Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
Date:2/17/2009

MOUNTAIN VIEW, Calif., Feb. 17 /PRNewswire/ -- Frost & Sullivan, the Growth Partnership Company, reaffirms its position that the economy is regaining its strength, thanks in part to an unprecedented US $1 trillion stimulus package from the US government and additional stimulus packages from foreign governments.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"President Obama's stimulus package is clearly serving to convince businesses and consumers that we can get back on track," explains David Frigstad, Chairman of Frost & Sullivan. "The program will stimulate optimism and let the U.S. -- and the rest of the world -- get back to business."

Firm executives also cite the following critical indicators as evidence that confidence and prosperity will soon be revived.

    -- Existing U.S. home sales are up 4.91%.
    -- U.S. retail sales are finally in the black, with January sales posting
       an increase of 1% from the previous month.
    -- High GDP rates in emerging markets
    -- Near-zero fed rates and high dividends in emerging economy stocks

Frost & Sullivan believes that businesses and consumers alike are allowing fear to adversely affect their judgment. By cutting spending and cutting costs, they only serve to perpetuate the economic downward spiral. "This irrational behavior needs to cease," states Frigstad, "or else companies will not be able to recover and return to growth."

The strength of Asian banks and financial services firms gives an indication that Asian companies will lead the global rebound. "New capitalist entrants and emerging markets will become a powerful driver of the global economy, and will have a huge impact going forward," concludes Frigstad.

To receive regular updates on the economy from Frost & Sullivan, subscribe to complimentary vertical industry Growth Opportunity Newsletters and register for a complimentary Chairman's Series on Growth webcast. For more information on these programs, please contact Jake Wengroff, 210.247.3806, jake.wengroff@frost.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages more than 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

     Contact:
     Jake Wengroff
     210.247.3806
     jake.wengroff@frost.com

'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
4. Signalife Wins Second Frost & Sullivan Technology Award
5. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
6. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Windsor, Connecticut (PRWEB) , ... June 23, 2016 ... ... will introduce a new line of intelligent tools designed, tuned and optimized exclusively ... place September 12–17 in Chicago. The result of a collaboration among several companies ...
Breaking Biology Technology:
(Date:6/1/2016)... Favorable Government Initiatives Coupled With ... Identification to Boost Global Biometrics System Market Through 2021  ... report, " Global Biometrics Market By Type, By ... 2011 - 2021", the global biometrics market is projected ... of growing security concerns across various end use sectors ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):